We are live on ! Find out more
PIM

Ponoi II Management Portfolio holdings

AUM $38.3M Turnover 0%
1-Year Est. Return 32.02%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
-32.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$38.3M
AUM Growth
+$1.46M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$17M 44.41%
1,298,908
– –
2020 Q4
7 quarters
RVMD icon
2
Revolution Medicines
RVMD
$41.7B
$13.5M 35.31%
685,011
– –
2020 Q4
7 quarters
NRIX icon
3
Nurix Therapeutics
NRIX
$2.84B
$4.26M 11.14%
327,123
– –
2020 Q4
7 quarters
RAPT icon
4
DELISTED
RAPT Therapeutics
RAPT
$3.5M 9.14%
18,175
– –
2020 Q4
7 quarters

Similar funds

Ponoi II Management's Q3 2022 Portfolio in Review

As of Q3 2022, Ponoi II Management held 4 positions worth $38.3M, up 4% from $36.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Ponoi II Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi II Management's ten largest holdings make up 100% of its $38.3M portfolio in Q3 2022.
  • Ponoi II Management opened 0 new positions and closed 0 in Q3 2022.
  • Ponoi II Management's portfolio value rose 4% quarter-over-quarter to $38.3M.

Based on Ponoi II Management's 13F filing for Q3 2022, filed 14 Nov 2022.